Results 191 to 200 of about 1,052,896 (217)

Nanotechnology: A promising approach of antiviral treatments against chikungunya virus (CHIKV)

Journal of Scientific and Innovative Research, 2018
Following its emergence in Africa, spread to the Indian Ocean islands in 2006, and occurrences in regions of the world where it hadn’t been reported in the past, Chikungunya has become an emerging public health concern in many countries. The past outbreaks of the chikungunya virus (CHIKV) have caused widespread morbidity and mortality.
Rishikesh Kumar, Ganesh C Sahoo, null Bhawna, Aparna Ramachandran, Md. Yousuf Ansari, Krishna Pandey, VNR Das, RK Topno, Major Madhukar, Pradeep Das   +9 more
openaire   +1 more source

Magnetic Resonance Imaging Brain Findings in Chikungunya Virus (CHIKV) Infection with Neurological Complication during Epidemic Outbreak

Neurology India, 2023
Background and Objective: The Chikungunya virus is an alphavirus RNA of the family Togaviridae transmitted by the Aedes mosquito. We aim to report magnetic resonance imaging (MRI) brain findings for neurological complications at our institute during epidemic outbreak. Materials and Methods:
Kanika Sekhri, Sethi, Abhay Kumar, Aryan, Prem Kumar, Ganeshan   +2 more
openaire   +2 more sources

Diagnosing the Outbreak and Spread of the Chikungunya Virus in Central & South America - The DARPA CHIKV Challenge

Journal of Clinical and Biomedical Advances, 2023
In 2014, the U.S. Defense Advanced Research Projects Agency (DARPA) issued a “challenge” to forecast the future outbreaks and spreads of the virus Chikungunya Virus (CHIKV) in Central and South America. We took on the challenge of predicting the cumulative number of Pacific Atlantic Health Organization (PAHO) reported Chikungunya or CHIKV cases by ...
openaire   +1 more source

Chikungunya Virus (CHIKV) Pathogenesis: From Acute Fever to Chronic Arthritis—Immune Mechanisms and Therapeutic Implications

Current Topics in Medicinal Chemistry
Chikungunya Virus (CHIKV) is an arthropod-borne alphavirus that represents a substantial worldwide health burden. A percentage of patients go on to suffer from Chronic Chikungunya Arthritis (CCA) that lasts for months, or even years, and causes disability.
Dongbing Li, Guizhen Lyu
openaire   +2 more sources

Chikungunya virus (CHIKV): What can be expected after the acute phase?

Reumatología Clínica (English Edition), 2016
Vianna J, Khoury, Pablo R, Camilo
openaire   +2 more sources

EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

Value in Health, 2022
K Bakker, H Hofstra, A Dijkstra, G Gurgel, B Wolters   +4 more
openaire   +1 more source

Chikungunya Virus (CHIKV) Serology Correlation with PCR at a Commercial�Laboratory Since Emergence of CHIKV in the Americas

2014
Batterman, Holly, Prince, Harry, Seaton, Brent, Schwab, Dale, Pesano, Rick   +4 more
openaire   +1 more source

Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine

Journal of Infectious Diseases, 2020
Barbara Schnierle, Sally A Baylis, Lia Laura Lewis-Ximenez   +2 more
exaly  

EPH15 Transmission Dynamics and Vaccination Strategies for Chikungunya Virus (CHIKV): An Outbreak Simulation Study in Rome, Italy

Value in Health, 2023
G. Tiozzo, B. Sloof, H. Hofstra, G.T. Vondeling, A. de Roo   +4 more
openaire   +1 more source

Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis

Virologica Sinica, 2019
Se Kim, Jihyun Yang, Haryoung Poo
exaly